A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

被引：0
|
作者：
Ma, K. [1 ]
Xu, Y. [1 ]
Cai, Y. [1 ]
Wang, X. [1 ]
Sun, C. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
small-cell lung cancer; Apatinib; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP10.05
引用
收藏
页码：S216 / S217
页数：2
相关论文
共 50 条
  • [31] Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy
    PerezSoler, R
    Fossella, FV
    Glisson, BS
    Lee, JS
    Murphy, WK
    Shin, DM
    Kemp, BL
    Lee, JJ
    Kane, J
    Robinson, RA
    Lippman, SM
    Kurie, JM
    Huber, MH
    Raber, MN
    Hong, WK
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 503 - 513
  • [32] Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer
    Igor M Bondarenko
    Antonella Ingrosso
    Paul Bycott
    Sinil Kim
    Cristina L Cebotaru
    BMC Cancer, 15
  • [33] A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer
    Bennouna, J
    Monnier, A
    Rivière, A
    Milleron, B
    Lemarie, E
    Trillet-Lenoir, V
    Soussan-Lazard, K
    Berille, J
    Douillard, JY
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (09) : 1107 - 1112
  • [34] Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer
    Bondarenko, Igor M.
    Ingrosso, Antonella
    Bycott, Paul
    Kim, Sinil
    Cebotaru, Cristina L.
    BMC CANCER, 2015, 15
  • [35] Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study
    Stathopoulos, G. P.
    Trafalis, D.
    Dimitroulis, J.
    Athanasiou, A.
    Koutantos, J.
    Anagnostopoulos, A.
    ONCOLOGY LETTERS, 2010, 1 (02) : 335 - 338
  • [36] A phase II trial of combination chemotherapy with irinotecan and amrubicin in pretreated patients with non-small cell lung cancer
    Segawa, Y.
    Nogami, N.
    Shinkai, T.
    Kiura, K.
    Tabata, M.
    Takigawa, N.
    Hotta, K.
    Shibayama, T.
    Ueoka, H.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    F Cappuzzo
    S Novello
    F De Marinis
    V Franciosi
    M Maur
    A Ceribelli
    V Lorusso
    F Barbieri
    L Castaldini
    E Crucitta
    L Marini
    S Bartolini
    G V Scagliotti
    L Crinò
    British Journal of Cancer, 2005, 93 : 29 - 34
  • [38] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    Cappuzzo, F
    Novello, S
    De Marinis, F
    Franciosi, V
    Maur, M
    Ceribelli, A
    Lorusso, V
    Barbieri, F
    Castaldini, L
    Crucitta, E
    Marini, L
    Bartolini, S
    Scagliotti, GV
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 29 - 34
  • [39] A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer
    Rossi, David
    Catalano, Vincenzo
    Alessandroni, Paolo
    Fedeli, Anna
    Fedeli, Stefano Luzi
    Giordani, Paolo
    Baldelli, Anna Maria
    Casadei, Virginia
    Ceccolini, Monica
    Ugolini, Marcello
    Dennetta, Donatella
    Catalano, Giuseppina
    CLINICAL LUNG CANCER, 2007, 8 (06) : 382 - 385
  • [40] A single-arm, prospective study of apatinib mesylate plus pemetrexed in patients of advanced non-squamous non-small cell lung cancer after failure of previous chemotherapy
    Dong, Shuang
    Ou, Wuling
    Zhong, Yi
    Zhu, Xianmin
    Cai, Qian
    Zhang, Jing
    Ran, Fengming
    Qian, Yu
    Wang, Jun
    Hu, Sheng
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
12345